Clinical Trial Update: Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing short versus long Celebrex therapy for knee osteoarthritis has completed. The provided snippet does not include the trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• CELEBREX (Celecoxib)

Snippet

Sponsor: Pfizer | Conditions: Osteoarthritis,Knee | Phase 3 | Status: COMPLETED